{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-005030","form_type":"8-K","ticker":"NVNO","cik":"0001661053","company_name":"enVVeno Medical Corp","filed_at":"2026-02-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.796078+00:00","generated_at":"2026-05-16T04:57:04.876060+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"enVVeno Medical regains Nasdaq minimum bid price compliance; reports $28M cash at year-end","bullets":["Received formal Nasdaq notice confirming compliance with minimum bid price rule; closing bid ≥ $1.00 for 10 consecutive business days Jan 20 - Feb 2, 2026, matter closed.","Cash and investments balance approximately $28 million as of December 31, 2025.","Company expects to share additional details on 2026 strategic plans in coming weeks; believes it is well-positioned for 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-005030","json":"https://secwatch.observer/filing/0001493152-26-005030.json","markdown":"https://secwatch.observer/filing/0001493152-26-005030.md","text":"https://secwatch.observer/filing/0001493152-26-005030.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661053/000149315226005030/0001493152-26-005030-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661053/000149315226005030/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T04:57:04.876060+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}